Literature DB >> 25652535

To monitor dabigatran or not: a matter of patient safety.

Hemamalini Ketha1, John R Mills2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25652535     DOI： 10.1373/clinchem.2014.232207

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  2 in total

Review 1.  Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases.

Authors:  Jens J Posma; Steven P Grover; Yohei Hisada; A Phillip Owens; Silvio Antoniak; Henri M Spronk; Nigel Mackman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-01       Impact factor: 8.311

2.  Dabigatran Monitoring Was Influenced by Thrombin Time Reagent With Different Thrombin Concentrations.

Authors:  Xiaoping Xu; Qian Liang
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.